Valcadia Healthcare Partners Advises CURC in its Acquisition by The START Center for Cancer Research
Valcadia Healthcare Partners LLC (“Valcadia”) a leading healthcare investment banking and M&A advisory firm, announced today that it has advised Carolina Urologic Cancer Center (“CURC”), the premier urologic clinical research site specializing in genitourinary oncology, in its acquisition by The START Center for Cancer Research, a global leader in early-phase oncology clinical trials. The transaction closed in April 2025 and represents Valcadia’s fourth completed outsourced pharma services transaction, a milestone which reflects the firm’s leadership in advising health sciences entrepreneurs and business owners.
Valcadia Healthcare Partners Announces Pharma Services M&A Transaction Closing
Valcadia Healthcare Partners LLC (“Valcadia” or “VHP”), an independent healthcare investment bank established in 2023, announces the closing of its first completed mergers and acquisition engagement, in February 2024. The transaction target, which was not disclosed, operates an outsourced clinical research services business focused on Alzheimer’s disease and liver disease and is based in the Southeastern United States. The acquirer is a private equity backed clinical research platform.
